Low Dose Induction for Pediatric Acute Myeloid Leukemia Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
the standard induction treatment for pediatric acute myeloid leukemia has high early morbidity and mortality that jeopardize the outcome especially in developing countries. SIOP recommended lower dose induction synergistic G- CSF to minimize these unwanted toxicities. the study aimed at minimizing the toxicities during induction without jeopardizing the survival.
Epistemonikos ID: 8fb02c6feb0029298b6c02262c23ffed908626f6
First added on: Oct 10, 2026